000 | 00992nam a2200277 a 4500 | ||
---|---|---|---|
008 | 980324s1991^^^^nyua^^^^^b^^^^001^0^eng^c | ||
020 | _a0824784847 (papel alcalino) | ||
035 | _aMX001000782344 | ||
040 |
_aDNLM/DLC _cDLC _dDLC |
||
041 | _aENG | ||
050 | 1 | 0 |
_aRM301.45 _bP43 1991 |
082 | 0 | 0 |
_a615.5/8 _220 |
245 | 0 | 0 |
_aPharmaceutical bioequivalence / _cedited by Peter G. Welling, Francis L.S. Tse, Shrikant V. Dighe |
264 | 1 |
_aNew York : _bM. Dekker, _cc1991 |
|
300 |
_aix, 467 páginas ; _bilustraciones ; |
||
336 |
_atexto _2rdacontent |
||
337 |
_asin medio _2rdamedia |
||
338 |
_avolumen _2rdacarrier |
||
490 | 0 |
_aDrugs and the pharmaceutical sciences ; _vv. 48 |
|
504 | _aIncluye referencias bibliograficas e indices. | ||
650 | 0 |
_aMedicamentos _xEquivalencia terapéutica |
|
650 | 0 |
_aMedicamentos _xBiodisponibilidad |
|
700 | 1 | 0 |
_aWelling, Peter G., _eeditor |
700 | 1 | 0 |
_aTse, Francis L. S., _eeditor |
700 | 1 | 0 |
_aDighe, Shrikant V., _eeditor |
999 |
_c1882 _d1882 |